Stoke Therapeutics (STOK) Insider Trading & Ownership $13.36 +0.31 (+2.38%) (As of 10:59 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Stoke Therapeutics (NASDAQ:STOK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$69.40 M Get STOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Stoke Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address STOK Insider Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Stoke Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/19/2024Skorpios TrustMajor ShareholderSell1,937,500$14.05$27,221,875.00 7/1/2024Barry TichoInsiderSell10,000$13.75$137,500.00 4/17/2024Skorpios TrustMajor ShareholderSell3,600,000$11.60$41,760,000.00 3/28/2024Jonathan AllanGeneral CounselSell5,126$13.20$67,663.20 3/19/2024Edward M Md KayeCEOSell11,150$6.10$68,015.00 3/19/2024Jonathan AllanGeneral CounselSell2,349$6.10$14,328.90 3/19/2024Stephen J TulipanoCFOSell4,116$6.10$25,107.60 2/1/2024Barry TichoInsiderSell10,000$4.80$48,000.00 1/2/2024Barry TichoInsiderSell10,000$5.74$57,400.00 (Data available from 1/1/2013 forward) STOK Insider Trading Activity - Frequently Asked Questions Who is on Stoke Therapeutics's Insider Roster? The list of insiders at Stoke Therapeutics includes Barry Ticho, Edward M Md Kaye, Huw M Nash, Jonathan Allan, Skorpios Trust, and Stephen J Tulipano. Learn more on insiders at STOK. What percentage of Stoke Therapeutics stock is owned by insiders? 11.30% of Stoke Therapeutics stock is owned by insiders. Learn more on STOK's insider holdings. Which Stoke Therapeutics insiders have been selling company stock? The following insiders have sold STOK shares in the last 24 months: Barry Ticho ($1,166,152.28), Edward M Md Kaye ($68,015.00), Jonathan Allan ($108,251.14), Skorpios Trust ($68,981,875.00), and Stephen J Tulipano ($25,107.60). How much insider selling is happening at Stoke Therapeutics? Insiders have sold a total of 5,681,555 Stoke Therapeutics shares in the last 24 months for a total of $70,349,401.02 sold. Stoke Therapeutics Key ExecutivesDr. Edward M. Kaye M.D. (Age 75)Ph.D., CEO & Director Compensation: $948.9kDr. Adrian R. Krainer Ph.D. (Age 65)Co-Founder & Independent Director Compensation: $44kDr. Barry S. Ticho FACC (Age 63)M.D., Ph.D., Chief Medical Officer Compensation: $684.55kMs. Isabel Aznarez Ph.D. (Age 51)Co-Founder & Group VP of Discovery Research Mr. Thomas Edward Leggett (Age 47)Chief Financial Officer Dr. Huw M. Nash Ph.D. (Age 57)COO & Chief Business Officer Compensation: $429.67kMr. Eric RojasHead of Investor RelationsMr. Jonathan Allan J.D. (Age 34)Corporate Secretary & General Counsel Ms. Dawn Kalmar (Age 46)Chief Communications Officer Ms. Joan WoodChief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies RVNC Insider Trades ARCT Insider Trades HRTX Insider Trades MRSN Insider Trades STTK Insider Trades CPRX Insider Trades AMPH Insider Trades CGON Insider Trades TWST Insider Trades ARWR Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors This page (NASDAQ:STOK) was last updated on 11/6/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredNASDAQ small cap that could be gearing up for a massive short squeeze.A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!Huge Alerts | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s Spending Plans Are Here (Here's What You Must Know)Trump's back in the White House, but here's what they're not telling you: his plans could cause inflation to s...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
